Recap: Jounce Therapeutics Q4 Earnings


Jounce Therapeutics JNCE reported its Q4 earnings results on Wednesday, March 2, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.


Jounce Therapeutics missed estimated earnings by 84.37%, reporting an EPS of $-0.59 versus an estimate of $-0.32.

Revenue was up $62.34 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 4.37% drop in the share price the next day.

Here's a look at Jounce Therapeutics's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.44 -0.36 -0.41 0.22
EPS Actual -0.59 -0.08 -0.58 0.86
Revenue Estimate 6.48M 8.18M 11.81M 39.27M
Revenue Actual 0 25.37M 1.54M 62.34M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsNewsBZI-Recaps